MT-5

N/A

Report date: 2024/12/06 10:45:01

Base Information

Drug NameMT-5
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell differentiation stimulantsNerve growth factor receptors agonists
TargetsNerve growth factor receptors
Therapy Area/IndicationsNeuroblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTaisho Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTaisho Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsNeuroblastoma

Other Information

ATC CodeN/A
Related LinksN/A